Actively Recruiting

Age: 18Years - 65Years
All Genders
NCT06095466

Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology

Led by Post Graduate Institute of Medical Education and Research, Chandigarh · Updated on 2023-10-23

150

Participants Needed

1

Research Sites

169 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cirrhotic cardiomyopathy is associated with increased risk of complications like hepatorenal syndrome, refractory ascites, impaired response to stressors including sepsis, bleeding or transplantation, poor health related quality of life and increased morbidity and mortality. Left ventricular diastolic dysfunction (LVDD) is associated with risk of hepatorenal syndrome (HRS) , septic shock. , heart failure in the perioperative period following liver transplantation, and after trans-jugular intrahepatic portosystemic shunt (TIPS) insertion . The echocardiographic E/e' ratio is a predictor of survival in LVDD, with multiple studies, including prospective data from our Centre.

CONDITIONS

Official Title

Cirrhotic Cardiomyopathy Based on Point-of-care Echocardiography, Biomarkers and Histology

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with cirrhosis diagnosed by clinical, biochemical, histological (if available), and ultrasound criteria
  • Age between 18 and 65 years
  • Cirrhosis with critical illness admitted to the Liver Intensive Care Unit
Not Eligible

You will not qualify if you...

  • Age over 65 years
  • Chronic renal disease
  • Pregnancy or peripartum cardiomyopathy
  • Valvular heart disease
  • Sick sinus syndrome or pacemaker
  • Transjugular intrahepatic portosystemic shunt (TIPS) insertion
  • Hepatocellular carcinoma
  • Anemia with hemoglobin less than 8 gm/dl in females, and less than 9 gm/dl in males at assessment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dr. Madhumita Premkumar

Sector-12, Chandigarh, India, 160012

Actively Recruiting

Loading map...

Research Team

M

Madhumita Premkumar

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here